期刊文献+

经微导管注射替罗非班联合硝普钠或硝酸甘油对择期经皮冠状动脉介入治疗中无复流的作用 被引量:19

Effects of tirofiban combined with nitroprusside or nitroglycerin injection through microcatheter on no-reflow phenomenon during elective percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨经微导管注射替罗非班联合硝普钠或硝酸甘油对择期经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗中无复流(no-reflow,NR)的即刻疗效。方法入选2012年3月至2014年5月在湛江中心人民医院行择期PCI治疗中发生无复流的患者61例,随机数字表法随机分为替罗非班联合硝普钠组31例,替罗非班联合硝酸甘油组30例。评价给药前、后冠状动脉血流心肌梗死溶栓试验(thrombolysis in myocardial infarction,TIMI)分级及校正TIMI帧数(corrected TIMI frame count,CTFC)并随访术后一周时的左心室射血分数。结果两组基线资料一致。给药10 min后,替罗非班联合硝普钠组有26例(83.9%)达到TIMI血流3级,校正CTFC为(32.3±11.9)帧,而替罗非班联合硝酸甘油组18例(60%)达到TIMI血流3级,CTFC为(40.1±14.5)帧,两组比较差异有统计学意义(P=0.04;P=0.02)。随访一周时,两组左心室射血分数比较,差异无统计学意义(52.9%±7.7%vs.51.6%±9.7%,P=0.56)。结论经微导管注射替罗非班联合硝普钠对择期PCI治疗中无复流的即刻血流改善效果优于替罗非班联合硝酸甘油。 Objectives To investigate the instant effects of tirofiban combined with nitroprusside or nitroglycerin injection through microcatheter on no-reflow(NR) phenomenon during elective percutaneous coronary intervention(PCI).Methods From March 2012 to May 2014, 61 patients who received elective PCI in Central People 's Hospital of Zhanjiang with NR phenomenon were randomly divided into tirofiban combined with nitroprusside group(n =31) and tirofiban combined with nitroglycerin group(n =30). Thrombolysis in myocardial infarction(TIMI) grade and corrected TIMI frame count(CTFC) of target coronary artery were detected before and 10 minutes after administration. Left ventricular ejection fraction(LVEF) at one-week follow-up was assessed. Results The baseline clinical data was comparable in the two groups. At 10 minutes after drug injection, there were 26(83.9%) patients with TIMI grade 3 in tirofiban combined with nitroprusside group, and 18(60%) patients in tirofiban combined with nitroglycerin group. The CTFC was 32.3 ±11.9 in tirofiban combined with nitroprusside group and 40.1 ±14.5 in tirofiban combined with nitroglycerin group. The differences in TIMI and CTFC between the two groups were significant(P =0.04;P =0.02,respectively). LVEF at one-week follow-up was 52.9% ±7.7% and 51.6% ±9.7% in the two groups, respectively, and the difference did not reach statistical significance(P=0.56). Conclusions Instant effect of tirofiban combined with nitroprusside injection through microcatheter on improvement of NR phenomenon during elective PCI is better than that of tirofiban combined with nitroglycerin.
出处 《岭南心血管病杂志》 2015年第4期466-469,共4页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 无复流现象 血管成形术 经腔 经皮冠状动脉 硝普钠 硝酸甘油 替罗非班 coronary artery disease no-reflow phenomenon percutaneous coronary intervention nitroprusside nitroglycerin tirofiban
  • 相关文献

参考文献9

二级参考文献52

  • 1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 2Valgimigli M, Pereoco G, Barbieri D, et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial[ J]. J Am Coll Cardiol, 2004,44( 1 ) :14-19. 被引量:1
  • 3The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I find- ings. TIMI Study Group[J]. N Engl J Med, 1985,312(14) :932-936. 被引量:1
  • 4马长生.冠心病介入治疗-技术与策略[M].第2版.北京:人民卫生出版社,2005.690-691. 被引量:1
  • 5Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during pri- mary percutaneous coronary intervention for acute myocardialinfarction on six-month mortality[J]. Am J Cardiol, 2007,99(4) :442-445. 被引量:1
  • 6Kotani J, Nanto S, Mintz GS, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-fellow phenomenon in pa- tients with acute coronary syndrome [ J ]. Circulation, 2002,106 (13) : 1672-1677. 被引量:1
  • 7Piana RN, Paik GY, Moscucei M, et al. Incidence and treatment of 'no-reflow'after percutaneous coronary intervention [ J ]. Circula- tion, 1994,89(6) :2514-2518. 被引量:1
  • 8Ishii H, Ichimiya S, Kanashiro M, et al. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in pa- tients withstress hyperglycemia[ J ]. Diabetes Care, 2006,29 (2) : 202 -206. 被引量:1
  • 9Botto N, Sbrana S, Trianni G, et al. An increased platelet - leu- kocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for " no - reflow" phenomenon? [J]. Int J Cardiol, 2007,117( 1 ) :123-130. 被引量:1
  • 10Balm DS, Wahr D, George B, et al. Randomized trial of a distal embol- ic protection device dttdng percutaneous intervention of saphenous vein aorto-coronary bypass grafts[ J]. Circulation, 2002,105(11 ) :1285-1290. 被引量:1

共引文献79

同被引文献138

引证文献19

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部